Gregory Piazza1, Ali Seddighzadeh, Samuel Z Goldhaber. 1. Cardiovascular Division, Beth Israel Deaconess Medical Center, 1 Deaconess Rd, Baker 4, Boston, MA 02215, USA. gpiazza@bidmc.harvard.edu
Abstract
BACKGROUND: Hospitalized patients with medical illness are especially susceptible to the development of venous thromboembolism (VTE). METHODS: To improve our understanding of the demographics, comorbidities, risk factors, clinical presentation, prophylaxis, and treatment of hospitalized medical patients with deep vein thrombosis (DVT), we evaluated hospitalized medical patients in a prospective registry of 5,451 consecutive ultrasound-confirmed DVT patients at 183 institutions in the United States. RESULTS: Of those patients who participated in the registry, 2,609 (48%) were hospitalized medical patients. Compared with 1,953 hospitalized nonmedical patients with DVT, medical patients with DVT experienced pulmonary embolism (PE) more often (22.2% vs 15.5%, respectively; p < 0.0001). However, medical patients in whom DVT developed had received VTE prophylaxis far less frequently than nonmedical patients (25.4% vs 53.8%, respectively; p < 0.0001). The underutilization of VTE prophylaxis among hospitalized medical patients extended to both pharmacologic and mechanical modalities. In a multivariable logistic regression analysis of all hospitalized VTE patients, status as a medical patient was negatively associated with receiving prophylaxis (adjusted odds ratio, 0.47; 95% confidence interval, 0.28 to 0.78). CONCLUSIONS: Hospitalized medical patients face "double trouble." First, during hospitalization for a reason other than VTE, VTE prophylaxis is omitted in medical patients more often than in nonmedical patients. Second, when VTE develops as a complication of hospitalization, hospitalized medical patients experience PE more often. Further studies should focus on understanding why prophylaxis is often omitted in hospitalized medical patients and on improving its implementation in this vulnerable population.
BACKGROUND: Hospitalized patients with medical illness are especially susceptible to the development of venous thromboembolism (VTE). METHODS: To improve our understanding of the demographics, comorbidities, risk factors, clinical presentation, prophylaxis, and treatment of hospitalized medical patients with deep vein thrombosis (DVT), we evaluated hospitalized medical patients in a prospective registry of 5,451 consecutive ultrasound-confirmed DVT patients at 183 institutions in the United States. RESULTS: Of those patients who participated in the registry, 2,609 (48%) were hospitalized medical patients. Compared with 1,953 hospitalized nonmedical patients with DVT, medical patients with DVT experienced pulmonary embolism (PE) more often (22.2% vs 15.5%, respectively; p < 0.0001). However, medical patients in whom DVT developed had received VTE prophylaxis far less frequently than nonmedical patients (25.4% vs 53.8%, respectively; p < 0.0001). The underutilization of VTE prophylaxis among hospitalized medical patients extended to both pharmacologic and mechanical modalities. In a multivariable logistic regression analysis of all hospitalized VTEpatients, status as a medical patient was negatively associated with receiving prophylaxis (adjusted odds ratio, 0.47; 95% confidence interval, 0.28 to 0.78). CONCLUSIONS: Hospitalized medical patients face "double trouble." First, during hospitalization for a reason other than VTE, VTE prophylaxis is omitted in medical patients more often than in nonmedical patients. Second, when VTE develops as a complication of hospitalization, hospitalized medical patients experience PE more often. Further studies should focus on understanding why prophylaxis is often omitted in hospitalized medical patients and on improving its implementation in this vulnerable population.
Authors: Emily C Alper; Ivan K Ip; Patricia Balthazar; Gregory Piazza; Samuel Z Goldhaber; Carol B Benson; Ronilda Lacson; Ramin Khorasani Journal: J Gen Intern Med Date: 2017-09-15 Impact factor: 5.128
Authors: Gregory Piazza; Erin J Rosenbaum; William Pendergast; Joseph O Jacobson; Robert C Pendleton; Gordon D McLaren; C Gregory Elliott; Scott M Stevens; William F Patton; Ousama Dabbagh; Marilyn D Paterno; Elaine Catapane; Zhongzhen Li; Samuel Z Goldhaber Journal: Circulation Date: 2009-04-13 Impact factor: 29.690
Authors: A Amin; A C Spyropoulos; P Dobesh; A Shorr; M Hussein; E Mozaffari; J S Benner Journal: J Thromb Thrombolysis Date: 2010-04 Impact factor: 2.300